262 related articles for article (PubMed ID: 12875772)
41. Left ventricular function and energy metabolism in middle-aged men undergoing long-lasting sustained aerobic oxidative training.
Perseghin G; De Cobelli F; Esposito A; Belloni E; Lattuada G; Canu T; Invernizzi PL; Ragogna F; La Torre A; Scifo P; Alberti G; Del Maschio A; Luzi L
Heart; 2009 Apr; 95(8):630-5. PubMed ID: 19008274
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of subclinical left ventricular dysfunction in diabetic patients: longitudinal strain velocities and left ventricular dyssynchrony by two-dimensional speckle tracking echocardiography study.
Zoroufian A; Razmi T; Taghavi-Shavazi M; Lotfi-Tokaldany M; Jalali A
Echocardiography; 2014 Apr; 31(4):456-63. PubMed ID: 24134395
[TBL] [Abstract][Full Text] [Related]
43. Left ventricular diastolic dysfunction in type 2 diabetes patients: a novel 2D strain analysis based on cardiac magnetic resonance imaging.
Chen Q; Gan Y; Li ZY
Comput Methods Biomech Biomed Engin; 2016 Sep; 19(12):1330-8. PubMed ID: 26838334
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of altered myocardial high energy phosphate metabolism in patients on maintenance dialysis using phosphorus-31 magnetic resonance spectroscopy.
Tagami T; Sakuma H; Matsumura K; Takeda K; Mori S; Takeuchi T; Nakano T
Invest Radiol; 1998 Mar; 33(3):171-6. PubMed ID: 9525756
[TBL] [Abstract][Full Text] [Related]
45. Impaired left ventricular energy metabolism in patients with hypertrophic cardiomyopathy is related to the extension of fibrosis at delayed gadolinium-enhanced magnetic resonance imaging.
Esposito A; De Cobelli F; Perseghin G; Pieroni M; Belloni E; Mellone R; Canu T; Gentinetta F; Scifo P; Chimenti C; Frustaci A; Luzi L; Maseri A; Maschio AD
Heart; 2009 Mar; 95(3):228-33. PubMed ID: 18708417
[TBL] [Abstract][Full Text] [Related]
46. Burden of Uncontrolled Metabolic Risk Factors and Left Ventricular Structure and Function in Patients With Type 2 Diabetes Mellitus.
Jørgensen PG; Jensen MT; Biering-Sørensen T; Mogelvang R; Fritz-Hansen T; Vilsbøll T; Rossing P; Jensen JS
J Am Heart Assoc; 2018 Oct; 7(19):e008856. PubMed ID: 30371320
[TBL] [Abstract][Full Text] [Related]
47. Tissue Doppler imaging for the detection and quantitation of myocardial dysfunction in patients with type 2 diabetes mellitus.
Von Bibra H; Thrainsdottir IS; Hansen A; Dounis V; Malmberg K; Rydén L
Diab Vasc Dis Res; 2005 Feb; 2(1):24-30. PubMed ID: 16305069
[TBL] [Abstract][Full Text] [Related]
48. Effects of exenatide on cardiac function, perfusion, and energetics in type 2 diabetic patients with cardiomyopathy: a randomized controlled trial against insulin glargine.
Chen WJY; Diamant M; de Boer K; Harms HJ; Robbers LFHJ; van Rossum AC; Kramer MHH; Lammertsma AA; Knaapen P
Cardiovasc Diabetol; 2017 May; 16(1):67. PubMed ID: 28526033
[TBL] [Abstract][Full Text] [Related]
49. Cardiac high-energy phosphate metabolism in patients with aortic valve disease assessed by 31P-magnetic resonance spectroscopy.
Neubauer S; Horn M; Pabst T; Harre K; Strömer H; Bertsch G; Sandstede J; Ertl G; Hahn D; Kochsiek K
J Investig Med; 1997 Oct; 45(8):453-62. PubMed ID: 9394098
[TBL] [Abstract][Full Text] [Related]
50. Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: randomized placebo-controlled trial.
Bizino MB; Jazet IM; Westenberg JJM; van Eyk HJ; Paiman EHM; Smit JWA; Lamb HJ
Cardiovasc Diabetol; 2019 Apr; 18(1):55. PubMed ID: 31039778
[TBL] [Abstract][Full Text] [Related]
51. [Early decrease in diastolic function in young type I diabetic patients as an initial manifestation of diabetic cardiomyopathy].
Schannwell CM; Schoebel FC; Heggen S; Marx R; Perings C; Leschke M; Strauer BE
Z Kardiol; 1999 May; 88(5):338-46. PubMed ID: 10413856
[TBL] [Abstract][Full Text] [Related]
52. Impact of Improved Glycemic Control on Cardiac Function in Type 2 Diabetes Mellitus.
Leung M; Wong VW; Hudson M; Leung DY
Circ Cardiovasc Imaging; 2016 Mar; 9(3):e003643. PubMed ID: 26962125
[TBL] [Abstract][Full Text] [Related]
53. Cardiac steatosis and left ventricular function in men with metabolic syndrome.
Nyman K; Granér M; Pentikäinen MO; Lundbom J; Hakkarainen A; Sirén R; Nieminen MS; Taskinen MR; Lundbom N; Lauerma K
J Cardiovasc Magn Reson; 2013 Nov; 15(1):103. PubMed ID: 24228979
[TBL] [Abstract][Full Text] [Related]
54. Left ventricular systolic and diastolic dysfunction and their relationship with microvascular complications in normotensive, asymptomatic patients with type 2 diabetes mellitus.
Mishra TK; Rath PK; Mohanty NK; Mishra SK
Indian Heart J; 2008; 60(6):548-53. PubMed ID: 19276494
[TBL] [Abstract][Full Text] [Related]
55. Interrelationship of left ventricular mass, systolic function and diastolic filling in normotensive morbidly obese patients.
Alpert MA; Lambert CR; Terry BE; Cohen MV; Mukerji V; Massey CV; Hashimi MW; Panayiotou H
Int J Obes Relat Metab Disord; 1995 Aug; 19(8):550-7. PubMed ID: 7489025
[TBL] [Abstract][Full Text] [Related]
56. Systolic and diastolic myocardial mechanics in hypertrophic cardiomyopathy and their link to the extent of hypertrophy, replacement fibrosis and interstitial fibrosis.
Nucifora G; Muser D; Gianfagna P; Morocutti G; Proclemer A
Int J Cardiovasc Imaging; 2015 Dec; 31(8):1603-10. PubMed ID: 26210792
[TBL] [Abstract][Full Text] [Related]
57. Brain death-induced alterations in myocardial workload and high-energy phosphates: a phosphorus 31 magnetic resonance spectroscopy study in the cat.
Brandon Bravo Bruinsma GJ; Nederhoff MG; te Boekhorst BC; Bredée JJ; Ruigrok TJ; van Echteld CJ
J Heart Lung Transplant; 1998 Oct; 17(10):984-90. PubMed ID: 9811406
[TBL] [Abstract][Full Text] [Related]
58. Mitral regurgitation: impaired systolic function, eccentric hypertrophy, and increased severity are linked to lower phosphocreatine/ATP ratios in humans.
Conway MA; Bottomley PA; Ouwerkerk R; Radda GK; Rajagopalan B
Circulation; 1998 May; 97(17):1716-23. PubMed ID: 9591766
[TBL] [Abstract][Full Text] [Related]
59. Determinants of subclinical diabetic heart disease.
Fang ZY; Schull-Meade R; Downey M; Prins J; Marwick TH
Diabetologia; 2005 Feb; 48(2):394-402. PubMed ID: 15645206
[TBL] [Abstract][Full Text] [Related]
60. Exacerbation of cardiac energetic impairment during exercise in hypertrophic cardiomyopathy: a potential mechanism for diastolic dysfunction.
Dass S; Cochlin LE; Suttie JJ; Holloway CJ; Rider OJ; Carden L; Tyler DJ; Karamitsos TD; Clarke K; Neubauer S; Watkins H
Eur Heart J; 2015 Jun; 36(24):1547-54. PubMed ID: 25990345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
